MELOXICAM TABLETS

The Defense Logistics Agency awarded a fixed-price delivery order, SPE2DP26F7691, to DMS Pharmaceutical Group Inc. (CAGE 1UNB0), a certified small business and Women-Owned Small Business, for the supply of 8 bottles of Meloxicam Tablets (NSN 6505015413243) at a total price of $360.00, with delivery required by July 15, 2026. The order is placed under the basic contract SPE2DX25D9900 and is intended for delivery to the USS OKANE DDG 77 at FPO AP 96674, with FOB Destination terms, meaning the contractor assumes all freight costs and responsibilities. Packaging and shipping require the use of the fastest traceable means, explicitly prohibiting parcel post, and all shipments must be marked with the base contract number SPE2DX-25-D-9900, the delivery order number SPE2DP-26-F-7691, and the transport control number R219516195HM37; no MIL-STD packaging or labeling specifications are referenced. Inspection and acceptance occur at the destination by the government, with no additional quality or testing standards cited beyond compliance with the NSN and basic contract requirements. Payment will be processed via DEF FIN AND ACCOUNTING SVC, BSM, using remittance address P O BOX 182317, COLUMBUS OH 43218-2317, under payment code SL4701. The contracting officer is Lisa Quinn of DLA Troop Support, Medical Supply Chain Pharm FSA, located in Philadelphia, PA. No contracting officer’s representative, special requirements such as security clearances or key personnel, option quantities, or modification history are identified in the order documentation. The award reflects a straightforward, low-value commercial pharmaceutical procurement under likely LPTA evaluation practices, governed by DLA acquisition procedures and federal small business certification rules, with no barcoding, preservation, or military standard specifications applied.